Introduction
Apoptosis is a programmed cell death that can be induced by a variety of different stimuli, such as growth factor deprivation (Cornelius et al., 2005) , ionizing radiation (Konemann et al., 2005) , chemotherapeutic drugs (Sordet et al., 2003) , ultraviolet (UV) radiation ) and activation of cell death receptors (Wajant et al., 2005) . Despite the fact that proapoptotic signals trigger a cascade of complex events and activate a variety of signal transduction pathways, all converge at the state of execution of apoptosis accompanied by activation of proteases and endonucleases. Membrane blebbing, cytosolic condensation, breakdown of nuclear DNA with subsequent nucleosomal fragmentation characterize cells dying in an apoptotic fashion. Finally, formation of well-enclosed apoptotic bodies enables phagocytic cells to remove apoptotic cells, minimizing tissue inflammation, avoiding damage to neighbouring cells and efficiently degrading host (or viral) DNA (Fries et al., 1999) . Because of its non-inflammatory features, apoptotic cell death not only serves as a protective mechanism removing damaged or altered cells and tissues but also represents an interesting target for anticancer therapy.
Ultraviolet radiation, in particular UVB with a wavelength range between 290 and 320 nm, represents one of the most important environmental factors because of its health hazardous effects, which include induction of skin cancer (Armstrong and Kricker, 2001) , suppression of the immune system (Beissert and Schwarz, 1999) and chronic skin damage (Fisher et al., 1996) . The biological effects of UV are multiple and include the release of soluble mediators, alterations of surface molecule expression and the induction of apoptosis. UVB-induced apoptosis is regarded as a protective mechanism preventing the generation of skin cancer by eliminating cells that harbour high amounts of UVB-induced DNA damage. Accordingly, UVB-induced DNA damage (cyclobutane pyrimidine dimers, o6-4> photoproducts) has been demonstrated to be the major molecular trigger for UVB-mediated cell death (Nakajima et al., 2004) . However, it has also been recognized that activation of death receptors (CD95/ Fas; tumour necrosis factor receptor 1 (TNF-R1); tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-R) and generation of reactive oxygen species contribute to the complete apoptotic response in an independent but additive fashion . Because of its protective features, alterations of UV-induced apoptosis may have a significant impact on photocarcinogenesis.
The nuclear factor kappa-B (NF-kB) family of transcription factors (Rel (c-Rel) , Rel A (p65), Rel B, NF-kB-1 (p105/p50), NF-kB-2 (p100/p52)) is involved mainly in stress-induced, immune and inflammatory responses. NF-kB can be activated by a variety of stimuli, including interleukin-1 (IL-1) and TNF-a, and among its multiple effects, it also induces antiapoptotic proteins (Dixit and Mak, 2002) . Therefore, NF-kB was generally considered to act predominantly as a mediator of cell survival. Accordingly, costimulation of keratinocyte cell line HaCaT and epithelial carcinoma cell line KB with IL-1 inhibited TRAILinduced apoptosis in an NF-kB-dependent manner through upregulation of the antiapoptotic proteins cIAP and FLIP (Kothny-Wilkes et al., 1998 Po¨ppelmann et al., 2005) . The same effect was observed for CD95-induced apoptosis, supporting the notion that NF-kB antagonizes apoptosis induced by different stimuli.
However, quite surprisingly, activation of NF-kB via IL-1 did not suppress but even enhanced UVB-induced apoptosis in these cell lines (Kothny-Wilkes et al., 1999) . This enhancement was associated with an increased release of TNF-a. Therefore, UVB appears to cause the conversion of NF-kB from an antiapoptotic mediator to a mediator of proapoptotic pathways by changing its transcriptional properties, consequently enhancing UVB-induced apoptosis. The mechanism includes NFkB-mediated repression of antiapoptotic genes, like cIAP and FLIP, as well as repression of genes encoding TNF-R1-associated adaptor proteins TRAF-1, TRAF-2 and TRAF-6 (Po¨ppelmann et al., 2005) . Another recent study revealed that TNF-a-mediated activation of NF-kB together with UVC or daunorubicin treatment manipulates NF-kB to interact with chromatin silencing histone deacetylases, thereby mediating specific gene repression of antiapoptotic genes, like cIAP and Bcl-2 (Campbell et al., 2004) .
As both UVB and daunorubicin induce DNA damage, we were curious to know whether the conversion of NF-kB from an anti-to a proapoptotic factor is specific for DNA-damaging agents. Thus, we studied the influence of IL-1-mediated NF-kB activation on apoptosis induced by g-radiation, UVB and UVA radiation and by the cytostatic drugs cisplatin, doxorubicin and etoposide. Here, we show that NF-kB-mediated enhancement of apoptosis is critically dependent on the type of DNA lesion induced and is always associated with TNF-a release.
Results
IL-1 þ UVB stimulation results in specific NF-kB-mediated release of TNF-a Based on the previous observation that enhancement of UVB-induced apoptosis by IL-1 is associated with increased release of TNF-a, we first studied whether the TNF-a release is dependent on the activation of NF-kB. Incubation of KB cells with IL-1 alone or with IL-1 þ UVB resulted in complete degradation of the NF-kB inhibitory protein IkBa within 15 min. Prestimulation with the proteasome inhibitors MG 132 or lactacystin as well as with the IkB kinase (IKK) inhibitor BAY-11-7082 for 1 h prevented IkBa degradation under these conditions, as did overexpression of an IkBa super-repressor variant (IkBsr), in which the essential phosphorylation sites Ser32/36 were mutated to Ala (Figure 1a) . Application of both proteasome inhibitors tested resulted in phosphorylation of IkBa (shifted band) but impeded proteasomal degradation. Inhibition of IKK by BAY-11-7082 even prevented phosphorylation of IkBa and the IkBsr variant remained completely unaffected by IL-17UVB stimulation. Only costimulation of cells with IL-1 þ UVB resulted in a strong release of TNF-a as determined 20 h after stimulation. TNF-a induction seems to be NFkB-dependent, as it could be inhibited by the application of each of the three inhibitors of IkBa degradation and by overexpression of IkBsr ( Figure 1b) . As published previously, costimulation of cells with IL-1 and death ligands (CD95 and TRAIL) did not result in any TNF-a release (Kothny-Wilkes et al., 1999; Po¨ppelmann et al., 2005) , indicating that the strong NF-kB-dependent TNF-a expression may be linked to UVB-induced DNA damage.
In contrast, expression of the proinflammatory cytokine IL-6, which is strongly induced by IL-1 in an NF-kB-dependent manner, remained unaffected by UVB, but could be inhibited by all three IkBa inhibitors and by overexpression of IkBsr (Figure 1c ). These data indicate that UVB-induced DNA damage and activated NF-kB synergize in selectively inducing TNF-a production.
NF-kB-mediated TNF-a release and enhancement of apoptosis does not universally apply for different DNA-damaging agents To prove whether IL-1-mediated enhancement of apoptosis and of TNF-a expression is specific for UVB or can be observed also upon application of other DNAdamaging agents, IL-1-treated cells were costimulated with cisplatin, etoposide, doxorubicin, UVB, UVA or g-radiation. Surprisingly, only cells treated with UVB, UVA or cisplatin showed enhanced apoptosis rates upon costimulation with IL-1. This effect seems to be strongly NF-kB-dependent, because it could be reversed in cells stably transfected with an IkBsr variant. In contrast, apoptosis rates induced by etoposide, doxorubicin and g-radiation remained unaffected by IL-1 and by overexpression of IkBsr (Figure 2a) . Enhancement of apoptosis always coincided with TNF-a release of more than 20 pg/ml, indicating that IL-1-mediated enhancement of DNA damage-induced apoptosis in fact requires pronounced TNF-a release, a concentration that is capable of triggering TNF-R1 (own unpublished data). TNF-a release as well as enhancement of apoptosis was reversed in IkBsr-overexpressing cells. In contrast, induction of apoptosis by DNA-damaging agents alone was not associated with TNF-a release (Figure 2b) . Again, IL-1-mediated IL-6 release remained completely unaffected by the different DNA-damaging agents applied ( Figure 2C ). This indicates that enhanced release of TNF-a upon combined exposure to IL-1 and DNA-damaging agents was not exclusively dependent on IL-1-mediated NF-kB activation but appears to be controlled by additional modifications within the cell. . Additionally, IL-1-or IL-1 þ UVB-treated cells were prestimulated with either the proteasome inhibitor MG132 (25 mM) (lanes 5 and 6), the IKK inhibitor BAY-11-7082 (30 mM) (lanes 7 and 8) or the proteasome inhibitor lactacystin (15 mM) (lanes 9 and 10) for 1 h. Finally, IL-1 and IL-1 þ UVB treatment was applied to KB cells stably overexpressing IkBsr (lanes 11, 12) . Fifteen minutes after IL-1 or IL-1 þ UVB stimulation, cellular proteins were extracted and subjected to Western blot analysis using an antibody directed against IkBa. Equal loading was monitored with an antibody against a-tubulin. Data presented show one representative out of three independently performed experiments. (b) KB cells were pretreated with MG132, lactacystin and BAY-11-7082 for 1 h. Subsequently, these cells and KB cells overexpressing IkBsr were stimulated with IL-1, UVB or costimulated with IL-1 þ UVB. Twenty hours later, TNF-a secretion in the supernatants was determined using a TNF-a ELISA. (c) The same supernatants were subjected to IL-6 ELISA to determine IL-6 release to the supernatant. Graphs presented show mean7s.d. of three independently performed experiments.
NF-jB differentially affects DNA damage-induced apoptosis E Strozyk et al Enhancement of UVB-induced apoptosis by IL-1 is abrogated by blocking TNF-R1 To confirm that IL-1-mediated and NF-kB-dependent enhancement of UVB-, cisplatin-and UVA-induced apoptosis is in fact dependent on TNF-R1 activation, the receptor was blocked utilizing an antagonistic Fab fragment (H398-Fab) and apoptosis rate determined in a cell death detection ELISA. Blockade of TNF-R1 significantly abrogated the enhancing effect of IL-1 on either UVB-, cisplatin-or UVA-induced apoptosis (Figure 3 ), indicating that activation of TNF-R1 plays a crucial role in the additive enhancement of apoptosis induced by the respective DNA-damaging agents.
Different DNA-damaging agents induce distinct types of DNA lesions Because of the observation that IL-1-mediated TNF-a release on the one hand seems to be associated with DNA damage, but on the other hand is not a general phenomenon triggered by induction of DNA damage, we surmised that different types of DNA lesions may account for the different cellular responses. Therefore, the types of DNA damage induced by the stimuli utilized in this study were characterized. To check for base modifications, genomic DNA isolated from cells exposed to the different DNA-damaging agents was subjected to Southwestern dot-blot analysis with antibodies directed against cyclobutane pyrimidine dimers (CPD) and oxo-7,8-dihydro-2 0 -deoxyguanosine (oxo 8 -G), respectively. As expected, only cells irradiated with either UVB or UVA showed generation of CPDs, being strongest upon UVB (Figure 4a ). Cisplatin induces formation of bulky adducts on DNA, which are similar to UVB-induced DNA modifications and thus are also removed by the nucleotide excision repair (Sun et al., 1996) .
Only cells treated with UVA, cisplatin or g-radiation revealed formation of oxidative base modifications, ) alone or in combination with IL-1. Subsequently, after cotreatment, antagonistic H398-Fab (30 mg/ml), which blocks activation of TNF-R1, was added to the cells. After 20 h, apoptosis was determined using a cell death detection ELISA. The rate of apoptosis reflects n-fold enrichment of nucleosomes released into the cytoplasm and is shown on the y axis. Data represent one out of three independently performed experiments with mean7s.d. of triplicates. 2 ), cisplatin (10 mg/ml), etoposide (10 mM), doxorubicin (2 mg/ml), UVA (250 kJ/m 2 ) or g-radiation (60 Gy) alone or in combination with IL-1. After 20 h, apoptosis was determined using a cell death detection ELISA. The rate of apoptosis reflects n-fold enrichment of nucleosomes released into the cytoplasm and is shown on the y axis. *Pp0.05. (b) Supernatants of the same cells were used to determine either TNF-a release or (c) IL-6 release using either TNF-a ELISA or IL-6 ELISA. Data presented show mean7s.d. of three independently performed experiments.
like oxo 8 -G (Figure 4b ). The weak signals in the other samples are owing to background staining of guanosine. To scrutinize for DNA strand breaks, comet assays were performed. Only cells treated with the toposiomerase inhibitors doxorubicin and etoposide or cells exposed to g-radiation displayed DNA strand breaks (Figure 4d ; see also Supplemetary Figure I ). This demonstrates that the apoptotic stimuli applied induced distinct and specific types of lesions within genomic DNA and may therefore differently influence TNF-a expression. The findings also indicate that induction of base modifications accounts for TNF-a expression, whereas induction DNA strand breaks inhibits this phenomenon.
Early NF-kB activation but not late NF-kB activation is IL-1 dependent upon induction of DNA strand breaks To clarify whether different DNA-damaging agents affect NF-kB activation or its DNA-binding abilities, electrophoretic mobility shift assay (EMSA) was performed with an NF-kB consensus sequence. Early NFkB activation determined after 30 min was shown to be critically dependent on IL-1, and therefore exclusively occurred in cells exposed to IL-1 only or cotreated with IL-1 and any apoptotic DNA damage-inducing stimulus ( Figure 5a ). Western blots further confirmed that early NF-kB activation concurs with IkBa degradation (Figure 5b ). In addition to the IL-1-dependent NF-kB activation, only the DNA strand break-inducing agents etoposide, doxorubicin and g-radiation activated NF-kB in an IL-1-independent manner at a later time point, 3 h after stimulation (Figure 5c ). Late IL-1-independent NF-kB activation does not coincide with an evaluable IkBa degradation, as demonstrated by Western blot analysis in Figure 5d , indicating this process to be either independent of IkBa degradation or it displays a much slower turnover kinetics than it is the case for IL-1-dependent NF-kB activation. , cisplatin (10 mg/ml), etoposide (10 mM), doxorubicin (2 mg/ml), UVA (250 kJ/m 2 ) or g-radiation (60 Gy). Subsequently, genomic DNA was extracted and subjected to Southwestern dot-blot analysis to detect base modifications utilizing antibodies specific for (a) CPD and (b) oxo-7,8-dihydro-2 0 -deoxyguanosine (oxo 8 ) after stripping the membrane. (c) Equal loading was monitored by reprobing the stripped membrane with an antibody directed against adenosine. (d) KB cells were treated as described above and subjected to a comet assay in order to detect induction of DNA strand breaks. Data presented show one representative out of three independently performed experiments. Figure 5 Influence of different DNA-damaging agents on NF-kB activation. KB cells were left untreated, stimulated with IL-1 alone (10 ng/ml) or treated with either UVB (300 J/m 2 ), cisplatin (10 mg/ ml), etoposide (10 mM), doxorubicin (2 mg/ml), UVA (250 kJ/m 2 ) or g-radiation (60 Gy) alone or in combination with IL-1. (a) 30 min later and (c) 3 h later, nuclear proteins were extracted and subjected to EMSA using a 32 P-labelled NF-kB consensus sequence. (b) Cells were treated as described above. 30 min later, proteins were extracted and Western blot analysis was performed utilizing an antibody directed against IkBa. Equal loading was monitored with an antibody directed against a-tubulin. (d) Cells were either left untreated or stimulated with etoposide (10 mM), doxorubicin (2 mg/ ml) or g-radiation (60 Gy) for 3 h. Subsequently, proteins were extracted and subjected to IkBa Western blot analysis. Data presented show one representative out of three independently performed experiments.
NF-jB differentially affects DNA damage-induced apoptosis E Strozyk et al Differences caused by the various DNA damage-inducing agents are not due to changes in the compositions of the NF-kB complexes Within the NF-kB family, activators (p65/RelA and c-Rel, RelB) and inhibitors of transcription (p50 and p52) exist. Especially, the IkB-independent activation of NFkB may imply that NF-kB molecules different from the transcriptional activator p65/p50 become activated (e.g. p50 or p52 homo-or heterodimers) and consequently may inhibit TNF-a expression (Thanos and Maniatis, 1995) . Thus, we checked the composition of activated NF-kB complexes 3 h after stimulation in a supershift analysis utilizing antibodies directed against p65, p50, p52, c-Rel and RelB, respectively. NF-kB molecules activated either in an IL-1-dependent or IL-1-independent fashion were shown to consist exclusively of p65/ p50 heterodimers, irrespective of the activating stimulus and the type of DNA lesion induced ( Figure 6 ). Thus, different compositions of the NF-kB complexes do not appear to account for the different biological effects observed.
NF-kB-mediated TNF-a mRNA expression is largely independent of the type of DNA damage Owing to our previous findings, we surmised that NFkB in combination with distinct DNA-damaging agents may differentially affect TNF-a transcription. However, semiquantitative RT-PCR analysis revealed that TNF-a transcription is upregulated upon all stimulations that cause NF-kB activation but independent of the DNAdamaging costimulus (Figure 7a ). Early IL-1-dependent as well as late IL-1-independent NF-kB activation resulted in transcriptional upregulation of TNF-a, Figure 6 IL-1-dependent and -independent activation of NF-kB results in nuclear translocation of p65/p50 heterodimers. (a) KB cells were stimulated with IL-1 (10 ng/ml) or IL-1 þ UVB (300 J/m 2 ), (b) with IL-1 þ cisplatin (10 ng/ml) or IL-1 þ UVA (250 kJ/m 2 ), (c) with etoposide (10 mM) alone or in combination with IL-1, (d) with doxorubicin (2 mg/ml) alone or in combination with IL-1, (e) exposed to g-radiation (60 Gy) alone or in combination with IL-1. After 3 h, nuclear extracts were subjected to EMSA using a 32 P-labelled NF-kB consensus sequence and compositions of the NF-kB complexes were analysed utilizing specific supershift antibodies directed against p65, p50, p52, cRel and RelB. Data presented show one representative out of three independently performed experiments.
NF-jB differentially affects DNA damage-induced apoptosis E Strozyk et al whereas late TNF-a induction appeared to be less intense (Figure 7a and b) . TNF-a expression was strongest in IL-1 þ UVB-treated cells, which also showed the strongest TNF-a secretion. The very rapid inhibition of transcription in doxorubicin-treated cells is probably owing to its potential to repress some of the NF-kB-driven genes. Accordingly, NF-kB induced by doxorubicin was found to bind endogenous loci and to assemble a histone deacetylase-dependent transcriptional repressor complex (Campbell et al., 2004) . Alternatively, repression may result from unstable binding of NF-kB to endogenous loci owing to deficiency of p65 in phosphorylation and acetylation (Ho et al., 2005) .
DNA strand break-inducing agents inhibit the release of TNF-a protein As TNF-a mRNA is generated in response to NF-kB activation independently of the DNA-damaging agent applied, but TNF-a secretion only occurs in cells cotreated with IL-1 þ UVB, UVA or cisplatin (Figure 2b ), we wanted to trace TNF-a protein within the cell. Irrespective of the particular treatment, cells never expressed membrane-bound TNF-a at the cell surface as demonstrated by FACS analysis (Figure 8a ). In contrast, increased intracellular levels of TNF-a could be detected upon IL-1 exposure, irrespective of the apoptotic costimulus as detected by intracellular FACS analysis of permeated cells (Figure 8b ). Protein data matched RNA data, suggesting that transcription and translation of TNF-a take place under all investigated conditions, but delivery to the membrane and shedding into the cell supernatant seem to be impaired in etoposide-, doxorubicin-and g-radiation-treated cells. Although the molecular mechanism by which the DNA strand break inducers inhibit the secretion of TNF-a remains to be determined, this explains why activation of NF-kB in the presence of strand breakinducing agents does not enhance apoptosis. In contrast, DNA-damaging agents, which induce base modifications, enhance the release of TNF-a upon activation of NF-kB and thereby enhance apoptosis. Together, these data indicate that induction of DNA damage can have significant impact on biological effects but it is the type of DNA damage that determines the final outcome.
Discussion
The present study was performed to further elucidate the mechanism that upon UVB radiation switches NFkB from an anti-to a proapoptotic factor. Previous studies have demonstrated that the enhancement of apoptosis under these conditions is crucially linked to an enhanced release of TNF-a. However, addition of equivalent amounts of TNF-a to irradiated cells did not significantly enhance apoptosis, indicating that additional intracellular processes have to be involved (Po¨ppelmann et al., 2005) . The enhanced sensitivity of UVB-irradiated cells to TNF-a was owing to a decreased expression of the antiapoptotic proteins FLIP and cIAP. In addition, TRAF-1, -2, and -6, signal transduction proteins involved in mediating cell survival via NF-kB activation, are downregulated upon UVB exposure and thus lead to a shift towards the proapoptotic pathway triggered by activation of TNF-R1 (Po¨ppelmann et al., 2005) .
One of the unique features of UVB radiation is its capacity to induce DNA damage, preferentially CPDs and /6-4S photoproducts (Nakajima et al., 2004) . It is known that UVB-induced DNA damage plays an important role in the signal transduction of a variety of biological effects of UVB radiation, as reduction of DNA damage, for example, via the application of exogenous DNA repair enzymes, is frequently associated with a loss or reduction of the respective biological effect . Thus, it seemed to be highly likely that UVB-mediated DNA damage is responsible or at least involved in the conversion of NFkB from an anti-to a proapoptotic mediator. This assumption has recently been strengthened by the observation that other DNA-damaging agents like UVC, doxorubicin and daunorubicin caused NF-kBdependent repression of the antiapoptotic proteins cIAP, Bcl-2 and survivin upon association with the NF-jB differentially affects DNA damage-induced apoptosis E Strozyk et al chromatin silencer histone deacetylase 3 (Campbell et al., 2004) .
The enhanced TNF-a release upon exposure to UVB plus IL-1 is certainly NF-kB-dependent, as inhibition of NFkB activation either by proteasome inhibitors, IKK inhibitors or by overexpression of an IkBa superrepressor variant prevented TNF-a release. This finding supported our hypothesis that UVB-induced DNA damage and activated NF-kB synergize in triggering TNF-a expression and release. The release of TNF-a appears to be a specific effect as IL-1-induced release of IL-6 remained completely unaffected by additional UVB exposure. This observation is in good accordance with previously published data showing that UVB-induced IL-6 release is independent of DNA damage, but dependent on direct activation of TNF-R1 by UVB in a ligand-independent fashion (Kulms et al., 2000) . The majority of experiments and the data shown here were obtained with KB cells, a human epidermoid carcinoma cell line derived from oral epithelium. However, representative experiments were performed and similar results achieved with HeLa cells and the spontaneously transformed keratinocyte cell line HaCaT.
There is clear evidence that DNA damage can have an impact on the activation of NF-kB. The death domain kinase RIP (receptor interacting protein) was found to play an important role in adriamycin-, campthothecinand ionizing radiation-mediated NF-kB activation, via NF-jB differentially affects DNA damage-induced apoptosis E Strozyk et al interaction with IKK in a TNF-R1/TRAF2-independent manner (Hur et al., 2003) . Furthermore, the nuclear serine-threonine kinase ataxia-telangiectasia mutated was shown to activate NF-kB utilizing the MEK/ERK/p90 rsk pathway in response to doxorubicin in a p53-independent fashion, thereby opposing the apoptotic response following DNA damage (Panta et al., 2004) . In contrast, a very recent study described activation of NF-kB by UVB via an unknown mechanism, which resulted in activation of the transcription factor Egr-1, followed by Egr-1-dependent activation of Gadd 45a/b, which are involved in the nucleotide excision repair. In contrast to the previous observations in which activation of NF-kB by DNA-damaging agents prevented apoptosis, this UVB-triggered cascade contributed to promotion of UVB-induced cell death in epidermal cells (Thyss et al., 2005) . This indicates that the impact of NF-kB activation on apoptosis can be heterogenous and thus appears to be a rather complex process.
Therefore, we were interested in whether the enhancement of UVB-induced apoptosis by activation of NF-kB is specific for UVB-induced DNA damage or applies also for other types of DNA lesions. The system established here to investigate the specific effect of different DNA-damaging agents on the behaviour of NF-kB within an epithelial cell model provides ideal conditions, because NF-kB is activated at equal levels independently of DNA damage via the IL-1-R activating pathway, a pathway that is generally not involved in apoptotic processes.
To address the issue of the specificity of DNA damage, we utilized different DNA-damaging agents including UVB, UVA, g-radiation, cisplatin, doxorubicin and etoposide. UVB induces primarily base modifications, in particular CPDs and /6-4S photoproducts. These damages are removed by the nucleotide excision repair. UVA primarily induces oxidative damage, especially oxo 8 -G, which is removed by base excision repair (Hailer et al., 2005) . In addition, there is NF-jB differentially affects DNA damage-induced apoptosis E Strozyk et al increasing evidence that UVA also can induce CPDs but certainly to a lesser degree than UVB (Besaratinia et al., 2005) . Cisplatin induces bulky adducts, which like UVBinduced damage are also removed by the nucleotide excision repair (Rosell et al., 2003) . In contrast, g-radiation, doxorubicin and etoposide primarily induce strand breaks. These damages are removed by homologous recombination and end joining (Hoeijmakers, 2001) . Our data suggest that the decision whether NF-kB enhances apoptosis is clearly dependent on the type of DNA lesion induced. Enhancement of apoptosis via the previously described TNF-a pathway was only induced by UVB, UVA and cisplatin, stimuli that primarily induce base modifications. In contrast, apoptosis induced by the DNA strand break-inducing agents (etoposide, doxorubicin and g-radiation) was not enhanced upon NF-kB activation. Accordingly, no enhanced release of TNF-a was observed upon these stimuli.
However, differences in TNF-a secretion were not the only discrepancy to be observed between DNA-modifying and DNA strand-breaking agents. Only incubation of cells with topoisomerase inhibitors doxorubicin, etoposide or exposition to g-radiation revealed a second delayed and IL-1-independent activation of NF-kB occurring 3 h after stimulation. The late NF-kB activation is likely to be mediated via p53, because it coincided with p53-Ser15 phosphorylation only upon treatment of cells with strand break-inducing agents (data not shown). p53 activation did not affect the downstream targets Bax or p21, which might contribute to either enhancement of apoptosis or cell cycle arrest (data not shown). As it has been shown previously that upon treatment with chemotherapeutic drugs, NF-kB can be activated in a p53-dependent manner through activation of the ribosomal S6 kinase 2 independent of the IKK pathway (Bohuslav et al., 2004) , we assume that p53 activation in our system also accounts for the late IL-1-independent NF-kB activation. In accordance with this, Ryan et al. reported that p53-mediated NF-kB activation upon doxorubicin treatment is mediated by the MAP kinase MEK1 and activation of the 90-kDa ribosomal S6 kinase pp90 rsk . p53-induced NF-kB activation correlated with its ability to induce apoptosis. Therefore, it was concluded that inhibition of NF-kB in tumours that retain wt-p53 may diminish the therapeutic effect of chemotherapeutic drugs (Ryan et al., 2000) .
Based on the observation that TNF-a release is crucially involved in enhancement of UV-induced apoptosis and that only agents inducing base modifications but not strand break-inducing agents triggered TNF-a release, we surmised that the type of DNA damage dictates the transcription of TNF-a, presumably by altering the TNF-a promoter. However, to our surprise, RT-PCR revealed significant induction of TNF-a mRNA upon exposure to both base modifications and strand break-inducing agents.
TNF-a is a membrane-bound molecule that upon de novo synthesis is exported from the trans-Golgi network to the plasma membrane in a protein kinase C (PKC)-dependent manner (Lee et al., 2000; Abdel-Raheem et al., 2005) . Once exposed to the plasma membrane, it can be sheded by different metalloproteinases belonging to the TNF-a-converting enzyme family (Mezyk et al., 2003) , resulting in the release of soluble TNF-a. However, when screening cells for surface expression of TNF-a, we found that none of the stimuli applied resulted in TNF-a expression, indicating that the halflife of membrane-bound TNF-a in IL-1 plus UVA, UVB or cisplatin-treated cells is extremely short and thus below the detection level. This indicates a very effective and systematic turnover to take place in order to enhance the apoptotic fate of the cell. When tracing TNF-a within the cell, we detected TNF-a intracellularly expressed upon treatment with IL-1 and any of the apoptotic costimuli. Intracellular levels of TNF-a were shown to be highest upon IL-1 þ UVB exposure, which correlates with the strongest mRNA upregulation and release of TNF-a upon this stimulation and argues for a high turnover at the translation level. For the other stimuli, except doxorubicin, the intracellular expression levels were comparable, indicating a high turnover also for UVA-and cisplatin-treated cells, which also respond with TNF-a release upon IL-1 cotreatment. In contrast, TNF-a seems to stay trapped within those cells treated with topoisomerase II inhibitors and g-radiation, indicating that possibly inhibition of PKC may be responsible for this phenomenon. However, treatment of cells with PKC inhibitors such as Go¨6976 and Go¨6983 had no effect on TNF-a secretion (data not shown).
Although the final mechanism controlling the TNF-a release in this system remains to be determined, the data clearly strengthen the essential contribution of TNF-a release and TNF-R1 activation to enhancement of DNA damage-induced apoptosis. As shown here, activation of NF-kB is not always associated with antiapoptotic activity but even can have proapoptotic effects. The type of DNA damage crucially determines the final outcome. Accordingly, inhibition of NF-kB may not always be associated with increased induction of apoptosis but also may contribute to apoptosis reduction. These observations should be carefully taken into account for applications of chemotherapeutics, especially in combination therapies with cytokines or NF-kB-inhibiting compounds (Sclabas et al., 2005; Xu et al., 2005; Zavarski et al., 2005) .
Materials and methods

Cells and reagents
The human oral epithelial carcinoma cell line KB (American Tissue Culture Collection, Rockville, MD, USA) was cultured in RPMI 1640 with 10% fetal calf serum (FCS). KB cells stably overexpressing a super-repressor variant of IkBa (IkBsr), in which the phophorylation sites Ser32/36 were mutated to Ala, was used to determine the contribution of NFkB to TNF-a release, IL-6 release and apoptosis enhanced by costimulation of cells with IL-1. Stimulations were carried out in colourless medium containing 2.5% FCS. To induce DNA damage and apoptosis, cells were either irradiated with 300 J/ m 2 UVB using a bank of six TL12 fluorescent bulbs (Philips, Eindhoven, The Netherlands), which emit most of their energy within the UVB range (280-320 nm) with an emission peak at 313 nm, with 250 kJ/m 2 UVA1 þ 2 using a bank of six TL09 fluorescent bulbs (Philips), which emit most of their energy within the UVA range (320-400 nm), or with 60 Gy g-radiation using a cobalt 60 source (1.1771.33 MeV). Alternatively, cells were treated with the different cytostatic drugs: doxorubicin (2 mg/ml of Adriablastin; Pharmacia Upjohn, Erlangen, FRG), etoposide (10 mM of Vepesid J; Bristol, Munich, FRG) and cisplatin (10 mg/ml of Platinex; Bristol). Recombinant human IL-1b (R&D Systems Inc., Minneapolis, MN, USA) was applied in a final concentration of 10 ng/ml. To block TNF-R1, a Fab fragment of TNF-R1 antagonistic antibody H398 was kindly provided by Peter Scheurich, Institute of Cell Biology and Immunology, University of Stuttgart and applied at a concentration of 30 mg/ml to the cells (Thoma et al., 1990) . The amount of TNF-a secreted from cells was measured with a human TNF-a ELISA (BioSource, Nivelles, Belgium) and IL-6 release with a Module Set ELISA (Bender MedSystems, Vienna, Austria). Inhibition of IkBa degradation was achieved either by addition of proteasome inhibitors MG132 (25 mM) and lactacystin (15 mM) or by preincubating cells with the IKK inhibitor BAY11-7082 (30 mM) (all from Calbiochem, Darmstadt, FRG).
Determination of cell death
Twenty hours after stimulation, cells were detached from culture dishes, and apoptosis was analysed in a cell death detection ELISA (Roche Diagnostics, GmbH, Mannheim, FRG) according to the manufacturer's protocol. The enrichment of mono-and oligonucleosomes released into the cytoplasm of cell lysates was detected by biotinylated antihistone-and peroxidase-coupled anti-DNA antibodies. Apoptosis rate was calculated according to the formula: absorbance of sample cells/absorbance of control cells, and reflects n-fold apoptosis. Unless otherwise stated, this factor was used as a parameter of apoptosis and is given as the mean7s.d. of three independently performed experiments. Statistical analysis was carried out using Student's t-test for two populations.
Western blot analysis
Cells were harvested and lysed in lysis buffer (50 mM Hepes, pH 7.5; 150 mM NaCl; 10% glycerol; 1% Triton X-100; 1.5 mM MgCl 2 ; 1mM ethyleneglycol tetraacetate (EGTA); 100 mM NaF; 10 mM pyrophosphate; 0.01% NaN 3 and Complete s protease inhibitor cocktail (Roche) for 15 min on ice. After centrifugation, supernatants were collected and the protein content measured by the DC BioRad Protein assay kit (BioRad, Hercules, CA, USA). Fifty micrograms of protein samples was subjected to 10% sodium dodecyl sulphatepolyacrylamide gel electrophoresis, blotted onto nitrocellulose membranes and incubated with an antibody directed against IkB-a (IMG-127; Imgenex Corp., San Diego, CA, USA). Equal loading was monitored by reprobing membranes with an antibody against a-tubulin (sc-5286; Santa Cruz Biotechnology Inc., San Diego, CA, USA). Horseradish peroxidase-conjugated secondary antibodies were purchased from Amersham, Buckinghamshire, UK. Bands were visualized by applying a chemiluminescense detection system (SuperSignal s West pico, Pierce Biotechnology Inc., Rockford, IL, USA).
Southwestern dot-blot analysis
For Southwestern dot-blot analysis, genomic DNA was extracted from cells according to the protocol from Puregene (Gentra Systems, Minneapolis, MN, USA) 30 min after stimulation. Two micrograms of genomic DNA was denaturated in 30 ml denaturation buffer (1.5 M NaCl; 0.5 M NaOH), vacuum dot-blotted onto a positively charged nylon membrane, neutralized with 100 ml neutralization buffer (1.0 M Tris; 2.0 M NaCl) and fixed by baking for 15 min at 801C. DNA damage was detected utilizing antibodies directed against cyclobutane-thymine dimers (KTM53; Kamiya Biomedical, Thousand Oaks, CA, USA) or oxo-7,8-dihydro-2 0 -deoxyguanosine (BD Pharmingen, San Diego, CA, USA). Equal loading was monitored by reprobing membranes with an antibody directed against adenosine (Research Plus Inc., Manasquan, NJ, USA).
Comet assay
Detection of DNA strand breaks by comet assay was carried out using a kit from Trevigen Inc. (Gaithersburg, MD, USA) . Briefly, cells were stimulated with DNA-damaging agents as described above. 30 min later, cells were washed with cold phosphate-buffered saline (PBS) and collected using a rubber policeman. Twenty microlitres of a 10 5 /ml cell suspension in PBS was transferred to 1.5 ml reaction tube and 200 ml of melted LM agarose (chilled to 371C) was added and mixed by pipeting. Fifty microlitres of the mixture were loaded onto a microscope slide and incubated for 20 min at 41C in the dark. Slides were immersed with chilled lysis buffer for 30 min on ice followed by a freshly prepared alkaline solution pH >13 (1.2% NaOH, 1 mM EDTA) for 30 min at room temperature (RT) in the dark, washed in TBE and run in horizontal electrophoresis at 1 V/cm for 10 min. Subsequently, samples were fixed in 70% ethanol, air-dried and stained with SYBR Green to be visualized in an OLYMPUS BX61 fluorescence microscope using FITC filter. Images were taken with an RTslider camera (Diagnostics Instruments Inc., Sterling Heights, MI, USA) connected to a computer equipped with MetaMorph software.
EMSA
Following stimulation, cells were harvested and resuspended in low-salt buffer A (10 mM HEPES, pH 7.9; 10 mM KCl; 0.1 mM EDTA; 0.1 mM EGTA; 1 mM dithiothreitol (DTT); 0.1 mM phenylmethylsulphonyl fluoride (PMSF) and Complete s ), incubated on ice for 20 min and passed 10 Â through a gauge needle (26G1/2). After centrifugation, nuclear pellets were resuspended in high-salt buffer C (20 mM HEPES, pH 7.9; 400 mM NaCl; 1 mM EDTA; 1 mM EGTA; 1 mM DTT; 0.1 mM PMSF and Complete s ), followed by intense shaking at 41C for 30 min. Nuclear lysates were cleared by centrifugation and the protein content determined by the DC Protein assay kit (BioRad). The NF-kB consensus oligonucleotide (sc-2505; Santa Cruz) was end-labeled using [g 32 -P]-ATP and T4 polynucleotide kinase (MBI Fermentas, Ontario, Canada), followed by column purification (QIAquick Nucleotide Removal Kit, Qiagen, Hilden, Germany). Binding reactions were carried out in a 20 ml volume containing 15 mg protein extract, 4 ml 5 Â binding buffer (20 mM HEPES, pH 7.5; 50 mM KCl; 2.5 mM MgCl 2 ; 20% (w/v) Ficoll; 1 mM DTT), 2 mg poly[dIdC], 2 mg BSA and 70 000 c.p.m. of 32 P-labelled NF-kB consensus oligonucleotide for 20 min at RT. For supershift assays, EMSA samples were incubated with 2 mg of the respective supershift antibody recognizing p65, p50, p52, c-Rel and RelB (sc-109X, sc-7178X, sc-7386, sc-70X, sc-226X; all Santa Cruz Biotechnology Inc.) for 20 min at RT. Reaction samples were separated on a 4% native PAGE at 150 V for 2.5 h and detected by autoradiography.
Semiquantitative RT-PCR Total RNA was extracted from cells using GIT-buffer followed by phenol/chloroform extraction (Chomczynski and Sacchi, 1987) utilizing Phase Lock Heavy tubes (Eppendorf AG, Hamburg, FRG). A 1.5 mg portion of total RNA was reverse transcribed with an AMV Reverse Transcriptase kit (Promega, Madison, WI, USA). The following primers were used in a 20 ml reaction utilizing the RedTaq polymerase system from Sigma (St Louis, MO, USA). b-Actin: F: 5 0 -AgAAAATCTggCACCACACC-3 0 ; R: 5 0 -CCATCTCTTgCT CgAAgTCC-3 0 ; TNF-a: F: 5 0 -TgCTTgTTCCTCAg CCTCTT-3 0 ; R: 5 0 -ATCCCAAAgTAgACCTgCCC-3 0 .
FACS analyses
For membrane-bound TNF-a detection, cells were harvested and resuspended in PBS þ 1% BSA at a final concentration of 2 Â 10 5 /100 ml. One microgram of primary antibody, anti-TNF-a T1 mouse IgG1, kindly provided by Peter Scheurich (Department of Cell Biology and Immunology, University of Stuttgart, Germany) or isotype control mouse IgG1 (Pharmingen) was incubated for 30 min on ice. Cells were washed, resuspended in 100 ml PBS þ 1% BSA and stained with goat anti-mouse IgG Ab conjugated to phycoerythrin (PE, 1:50) (Santa Cruz) for 30 min on ice. Chinese hamster ovary cells (CHO-hTNF-02-12) expressing membrane-bound human TNF-a served as positive control.
For intracellular TNF-a detection, cells were harvested, washed with PBS and fixed with 0.8% paraformaldehyde in PBS for 5 min on ice. After washing, cells were permeated with 0.3% saponine (Sigma) in PBS and incubated with the first antibody (anti-TNF-a) overnight at 41C. After washing, the secondary PE-labelled antibody was incubated in 0.3% saponine for 30 min on ice. Chinese hamster ovary cells (CHO-hTNF-wt) expressing wild-type human TNF-a served as positive control.
Cells were washed, resuspended in 400 ml PBS þ 1% BSA and analysed using FACS-Calibur flow cytometer (Becton Dickinson, San Jose, CA, USA) equipped with CELLQuestPro software. A minimum of 10 000 cells per sample were aquired in list mode and analysed with WinMDI 2.8 software.
Abbreviations
IkBa, inhibitor of kappa-B; IKK, IkB kinase; IL-1, interleukin-1; NF-kB, nuclear factor kappa-B; TNF-a, tumor necrosis factor-a.
